Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Valeritas Holdings Inc. VLRXQ

Valeritas Holdings Inc is a commercial-stage medical technology company. It is engaged in the business of improving health and simplifying life for diabetic patients by developing and commercializing innovative technologies. The company designed its first commercialized product, the V-Go Wearable Insulin Delivery Device, or V-Go, that supports the patients with Type 2 diabetes who need insulin to achieve and maintain their target blood glucose goals. V-Go is a small easy-to-use disposable insuli


OTCPK:VLRXQ - Post by User

Comment by dmacdon Nov 15, 2018 4:01pm
64 Views
Post# 28982521

RE:RE:Great Potential

RE:RE:Great PotentialYep. Massive dilution with major haircut on SP. Distribution agreement revenue pushed out to 2020 per conf call. Prospectus says 44m x $.68/sh with double warrants. Not stated if the SP is firm so could be lower still based on some other recent financings. Currently have 2 qtr burn rate and this will roughly add 2 or 3 qtrs. Lots of hope that management will deliver results.
<< Previous
Bullboard Posts
Next >>